The Italian Network for Tumor Biotherapy (NIBIT): getting together to push the field forward.
Maio M,
Nicolay HJ,
Ascierto P,
Belardelli F,
Camerini R,
Colombo MP,
Queirolo P,
Ridolfi R,
Russo V,
Anzalone L,
Fonsatti E,
Parmiani G.
Division of Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. mmaio@cro.it
As for a consolidated tradition, the 5th annual meeting of the Italian Network for Cancer Biotherapy took place in the Certosa of Pontignano, a Tuscan monastery, on September 20-22, 2007. The congress gathered more than 40 Italian leading groups representing academia, biotechnology and pharmaceutical industry. Aim of the meeting was to share new advances in cancer bio-immunotherapy and to promote their swift translation from pre-clinical research to clinical applications. Several topics were covered including: a) molecular and cellular mechanisms of tumor escape; b) therapeutic antibodies and recombinant constructs; c) clinical trials up-date and new programs; d) National Cooperative Networks and their potential interactions; e) old and new times in cancer immunology, an "amarcord". Here, we report the main issues discussed during the meeting.
PMID: 18269750 [PubMed - indexed for MEDLINE]
PMCID: PMC2275223